Central African Republic vs Laos: Access to anti-retroviral drugs, male (%)
Central African Republic
61.0%
in 2024
Laos
61.0%
in 2024
Central African Republic rank
97th
Laos rank
97th
Access to anti-retroviral drugs, male (%) over time
- Central African Republic
- Laos
How they compare
Central African Republic currently reports 61.0% against 61.0% in Laos, a difference of 0.0%.
The two have swapped places 4 times across 24 shared years of data; in 2000 it was Laos ahead.
Central African Republic ranks 97th and Laos ranks 97th of 141 countries.
Across the 3 decades both report, Central African Republic averaged higher in 1 and Laos in 2.
Head to head by decade
| Decade | Central African Republic | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.6% | 5.8% | 2.2% | Laos |
| 2010s | 24.1% | 25.4% | 1.3% | Laos |
| 2020s | 53.0% | 51.4% | 1.6% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Central African Republic or Laos?
- Central African Republic, at 61.0% against 61.0% in Laos as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Central African Republic and Laos?
- 0.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Laos?
- 24 years are reported by both, from 2000 to 2024.
- How do Central African Republic and Laos rank globally for access to anti-retroviral drugs, male?
- Central African Republic ranks 97th and Laos ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.